HopeStage
Back to all studies
UnknownNCT01900886

Personality Disorders for Hepatitis C, Chronic; Personality Disorders in Prison

This study has an unknown status in Spain. It is testing personality Disorders for Hepatitis C, Chronic; Personality Disorders in Prison.

Personality disorders, Hepatitis C, Chronic, ...ObservationalFrom 18 Years to 65 Years
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
Almería, Spain · Badajoz, Spain and 9 more locationsSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateDecember 2010
Recruitment status
Unknown
Enrollment listed in the registry
263
Sponsor
Grupo de Enfermedades Infecciosas de la Sociedad Española de Sanidad Penitenciaria
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Medication / drug, OTHER
Study phase
Not clearly listed
Locations
Spain
Age range
From 18 Years to 65 Years
Official registry ID
NCT01900886
Official title
Prospective Observational Study to Assess Personality Disorders in Prison Populations for Hepatitis C Treatment. "

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT01900886. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Status unknown

Almería · Badajoz · Jerez de la Frontera

8 more locations
  • Las Palmas de Gran Canaria
  • Santa Cruz de Tenerife
  • Córdoba
  • Albolote
  • Jaén
  • Salamanca
  • Seville
  • Ocaña
Registry details
Registry conditions (original wording)

Hepatitis C, Chronic; Personality Disorders in Prison

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Grupo de Enfermedades Infecciosas de la Sociedad Española de Sanidad Penitenciaria.

Does this study involve medication?

Yes. The study involves medication, including Ribavirin.

Who can participate?

Listed age limits: 18 years to 65 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me